Sympathetic overstimulation during critical illness: Adverse effects of adrenergic stress

Journal of Intensive Care Medicine

Volumn 24, Issue 5, 2009, Pages 293-316

  Dünser, Martin W ^a   Hasibeder, Walter R ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Krankenhaus der Barmherzigen Schwestern   (Australia)

Author keywords

Adrenergic stress; Adverse effects; Critical illness; Heart; Sympathetic nervous system

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMIODARONE; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; DEXMEDETOMIDINE; DIAZEPAM; DOPAMINE; ESMOLOL; FLUDROCORTISONE; FLUMAZENIL; HYDROCORTISONE; LEVOSIMENDAN; METOPROLOL; MIDAZOLAM; MIVAZEROL; NEUROPEPTIDE Y; NITRATE; NORADRENALIN; OPIATE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PROPOFOL;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; BLOOD CLOTTING; BONE MARROW; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG MECHANISM; FLUID THERAPY; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPOTENSION; IMMUNE SYSTEM; LUNG EDEMA; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKELETAL MUSCLE; STRESS; TACHYCARDIA; VASODILATATION;

BLOOD COAGULATION; BONE MARROW; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; CRITICAL ILLNESS; EPINEPHRINE; HEART; HUMANS; IMMUNE SYSTEM; LUNG; MUSCLE, SKELETAL; NOREPINEPHRINE; OXYGEN CONSUMPTION; RECEPTORS, ADRENERGIC; STRESS, PHYSIOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 70349331059     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066609340519     Document Type: Review

References (289)

1. Aronson JK "Where name and image meet"-the argument for "adrenaline". BMJ. 2000 ; 320 (7233). 506-509.
2. Guyton AC, Hall JE The autonomic nervous system; and the adrenal medulla. In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology. Philadelphia, PA: W.B. Saunders; 2000: 697-708.
3. Power I., Kam P. The autonomic nervous system. In: Power I, Kam P, eds. Principles of Physiology for the Anaesthetist. London, England: Edward Arnold; 2001: 57-62.
4. Lyte M. Microbial endocrinology and infectious disease in the 21st century. Trends Micrbiol. 2004 ; 12 (1). 14-20.
5. Guimarães S., Moura D. Vascular adrenoreceptors: an update. Pharmacol Rev. 2001 ; 53 (2). 319-356.
6. Guyton AC, Hall JE Receptors on the effector organs. In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology. Philadelphia, PA: W.B. Saunders ; 2000: 700.
7. Bevan JA, Bevan RD, Duckles SP Adrenergic regulation of vascular smooth muscle. In: Bohr DF, Somlyo AP, Sparks HV, eds. Handbook of Physiology - Cardiovascular System. Baltimore, MD: Williams & Wilkins; 1980: 515-566.
8. Flavahan NA, Cooke JP, Shepherd JT, Vanhoutte PM Human postjunctional alpha-1 and alpha-2 adrenoceptors: differential distribution in arteries of the limbs. J Pharmacol Exp Ther. 1987 ; 241 (2). 361-365.
9. Bevan JA, Duckworth J., Laher I., Oriowo MA, McPherson GA, Bevan RD Sympathetic control of cerebral arteries: specialization in receptor type, reserve, affinity, and distribution. FASEB J. 1987 ; 1 (3). 193-198.
10. Bohr DF Adrenergic receptors in coronary arteries. Ann N Y Acad Sci. 1967 ; 139 (3). 799-807.
11. Wortsman J., Frank S., Cryer PE Adrenomedullary response to maximal stress in humans. Am J Med. 1984 ; 77 (5). 779-784.
12. Maddens M., Sowers J. Catecholamines in critical care. Crit Care Clin. 1987 ; 3 (4). 871-882.
13. Jones SB, Romano FD Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats. Circ Shock. 1989 ; 28 (1). 59-68.
14. Boldt J., Menges T., Kuhn D., Diridis C., Hempelmann G. Alterations in circulating vasoactive substances in the critically ill - a comparison between survivors and nonsurvivors. Intensive Care Med. 1995 ; 21 (3). 218-225.
15. Benedict CR, Rose JA Arterial norepinephrine changes in patients with septic shock. Circ Shock. 1992 ; 38 (3). 165-172.
16. Schmidt H., Müller-Werdan U. Autonomic dysfunction in critically ill patients. Internist (Berl). 2002 ; 43 (9). 1099-1104. (Pubitemid 36061278)
17. Haji-Michael PG, Vincent JL, Degaute JP, van de Borne P. Power spectral analysis of cardiovascular variability in critically ill neurosurgical patients. Crit Care Med. 2000 ; 28 (7). 2578-2583.
18. Schmidt H., Müller-Werdan U., Hoffmann T., et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005 ; 33 (9). 1994-2002.
19. Schmidt H., Werdan K., Müller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care. 2001 ; 7 (5). 314-322.
20. Bucher M., Kees F., Taeger K., Kurtz A. Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med. 2003 ; 31 (2). 566-571.
21. Bernardin G., Strosberg AD, Bernard A., Mattei M., Marullo S. Beta-adrenergic receptor-dependent and- independent stimulation of adenylate-cyclase is impaired during severe sepsis in humans. Intensive Care Med. 1998 ; 24 (12). 1315-1322.
22. Annane D., Bellissant E., Cavaillon JM Septic shock. Lancet. 2005 ; 365 (9453). 63-78.
23. Marik PE Management of the critically ill geriatric patient. Crit Care Med. 2006 ; 34 (9 suppl). S176 - S182.
24. Sackner-Bernstein JD, Mancini DM Rationale for treatment of patients with chronic heart failure with adrenergic blockade. JAMA. 1995 ; 274 (18). 1462-1467.
25. Opie LH Receptors and signal transduction. In: Opie LH, ed. Heart Physiology. From Cell to Circulation. Philadelphia, PA: JB Lippincott Co; 2004: 186-220.
26. Guyton AC, Hall JE Cardiac output, venous return, and their regulation. In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology. Philadelphia, PA: WB Saunders Co; 2000: 210-222.
27. Power I., Kam P. Cardiovascular Physiology. In: Power I, Kam P, eds. Principles of Physiology for the Anaesthetist. London, England: Edward Arnold ; 2001: 99-165.
28. Jafri SM, Lavine S., Field BE, Bahorozian MT, Carlson RW Left ventricular diastolic function in sepsis. Crit Care Med. 1990 ; 18 (7). 709-714.
29. Bouhemad B., Nicolas-Robin A., Arbelot C., Arthaud M., Féger F., Rouby JJ Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med. 2008 ; 36 (3). 766-774.
30. Munt B., Jue J., Gin K., Fenwick J., Tweeddale M. Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med. 1998 ; 26 (11). 1829-1833.
31. Habib G. Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality. Clin Ther. 1997 ; 19 (suppl A). 39-52.
32. Reich DL, Bennett-Guerrero E., Bodian CA, Hossain S., Winfree W., Krol M. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg. 2002 ; 95 (2). 273-277.
33. Hartmann B., Junger A., Röhrig R., et al. Intraoperative tachycardia and peri-operative outcome. Langenbecks Arch Surg. 2003 ; 388 (4). 255-260.
34. Cook S., Togni M., Schaub MC, Wenaweser P., Hess OM High heart rate: a cardiovascular risk factor ? Eur Heart J. 2006 ; 27 (20). 2387-2393.
35. Palatini P., Benetos A., Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs. 2006 ; 66 (2). 133-144.
36. Raby KE, Brull S., Timimi F., et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999 ; 88 (3). 477-482.
37. Landesberg G., Luria MH, Cotev S., et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet. 1993 ; 341 (8847). 715-719.
38. Priebe J. Perioperative myocardial infarction - aetiology and prevention. Br J Anaesth. 2005 ; 95 (1). 3-19.
39. Sander O., Welters ID, Foëx P., Sear JW Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005 ; 33 (1). 81-88.
40. Ariati S., Brenna S., Prencipe L., et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000 ; 26 (1). 31-37.
41. Indolfi C., Ross J. Jr. The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching. Prog Cardiovasc Dis. 1993 ; 36 (1). 61-74.
42. Berman M., Fischman AJ, Southern J., et al. Myocardial adaptation during and after sustained, demand-induced ischemia. Circulation. 1996 ; 94 (4). 755-762.
43. Landesberg G., Zhou W., Aversano T. Tachycardia-induced subendocardial necrosis in acutely instrumented dogs with fixed coronary stenosis. Anesth Analg. 1999 ; 88 (5). 973-979.
44. Rowell LB Circulatory adjustments to dynamic exercise. In: Rowell LB, ed. Human Circulation. Regulation During Physical Stress. New York, NY: Oxford University Press; 1986: 213-256.
45. Dorian P. Antiarrhythmic action of beta-blockers: potential mechanisms. J Cardiovasc Pharmacol Ther. 2005 ; 10 (suppl I). S15 - S22.
46. Mayr A., Knotzer H., Pajk W., et al. Risk factors associated with new onset tachyarrhythmias after cardiac surgery - a retrospective analysis. Acta Anaesthesiol Scand. 2001 ; 45 (5). 543-549.
47. Culling W., Penny WJ, Cunliffe G., Flores NA, Sheridan DJ Arrhythmogenic and electrophysiological effects of alpha adrenoreceptor stimulation during myocardial ischemia and reperfusion. J Mol Cell Cardiol. 1987 ; 19: 251-258.
48. Elhendy A., van Domburg RT, Bax JJ, et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest. 2000 ; 117 (3). 649-656.
49. Nanda AS, Feldman A., Liang CS Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy. Clin Cardiol. 1995 ; 18 (7). 421-423.
50. Mayer SA, Lin J., Homma S., et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999 ; 30 (4). 780-786.
51. Dote K., Sato H., Tateishi H., Uchida T., Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991 ; 21 (2). 203-214.
52. Kawai S., Suzuki H., Yamaguchi H., et al. Ampulla cardiomyopathy ('Takotsubo' cardiomyopathy) - reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J. 2000 ; 64 (2). 156-159.
53. Desmet WJ, Adriaenssens BF, Dens JA Apical ballooning of the left ventricle: first series in white patients. Heart. 2003 ; 89 (9). 1027-1031.
54. Gianni M., Dentali F., Grandi AM, Summer G., Hiralal R., Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006 ; 27 (13). 1523-1529.
55. Haghi D., Fluechter S., Suselbeck T., et al. Takotsubo cardiomyopathy (acute left ventricular apical ballooning syndrome) occurring in the intensive care unit. Intensive Care Med. 2006 ; 32 (7). 1069-1074.
56. Park JH, Kang SJ, Song JK, et al. Left ventricular apical ballooning due to severe physical stress in patients admitted to the medical ICU. Chest. 2005 ; 128 (1). 296-302.
57. Ellrodt AG, Riedinger MS, Kimchi A., et al. Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Heart J. 1985 ; 110 (2). 402-409.
58. Akashi YJ, Nakazawa K., Sakakibara M., Miyake F., Musha H., Sasaka K. 123I-MIBG myocardial scintigraphy in patients with 'takotsubo' cardiomyopathy. J Nucl Med. 10 04; 45 (7). 1121-1127.
59. Kurisu S., Inoue I., Kawagoe T., et al. Time course of electrocardiographic changes in patients with tako-tsubo syndrome: comparison with acute myocardial infarction with minimal enzymatic release. Circ J. 2004 ; 68 (1). 77-81.
60. Ito K., Sugihara H., Katoh S., Azuma A., Nakagawa M. Assessment of Takotsubo (ampulla) cardiomyopathy using 99mTc-tetrofosmin myocardial SPECTcomparison with acute coronary syndrome. Ann Nucl Med. 2003 ; 17 (2). 115-122.
61. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005 ; 352 (6). 539-548.
62. Sametz W., Metzler H., Gries M., et al. Perioperative catecholamine changes in cardiac risk patients. Eur J Clin Invest. 1999 ; 29 (7). 582-587.
63. Kumar A., Jenkins LA, Perez-Verdia A., Roongsritong C. Transient left ventricular apical ballooning during dobutamine myocardial perfusion imaging. Int J Cardiol. 2008 ; 124 (3). 378-380.
64. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2 008; 36 (1). 296-327.
65. Bybee KA, Prasad A., Barsness GW, et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004 ; 94 (3). 343-346. (Pubitemid 38962701)
66. Hinojosa-Laborde C., Chapa I., Lange D., Haywood JR Gender differences in sympathetic nervous system regulation. Clin Exp Pharmacol Physiol. 1999 ; 26 (2). 122-126.
67. Sader MA, Celermajer DS Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res. 2002 ; 53 (3). 597-604.
68. Mann DL, Kent RL, Parsons B., Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992 ; 85 (2). 790-804.
69. Okamoto T., Adachi K., Muraishi A., Seki Y., Hidaka T., Toshima H. Induction of DNA breaks in cardiac myoblast cells by norepinephrine. Biochem Mol Biol Int. 1996 ; 38 (4). 821-827.
70. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways ? Exp Physiol. 2004 ; 89 (4). 407-416.
71. Goldspink DF, Burniston JG, Tan LB Cardiomyocyte death and the ageing and failing heart. Exp Physiol. 2003 ; 88 (3). 447-458.
72. Sinagra G., Bussani R., Abbate A., et al. Left ventricular diastolic filling pattern at Doppler echocardiography and apoptotic rate in fatal acute myocardial infarction. Am J Cardiol. 2007 ; 99 (3). 307-309.
73. Gaudino M., Anselmi A., Abbate A., et al. Myocardial apoptosis predicts postoperative course after aortic valve replacement in patients with severe left ventricular hypertrophy. J Heart Valve Dis. 2007 ; 16 (4). 344-348.
74. Iwai-Kanai E., Hasegawa K., Araki M., Kakita T., Morimoto T., Sasayama S. Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation. 1999 ; 100 (3). 305-311.
75. Todd GL, Baroldi G., Pieper GM, Clayton FC, Eliot RS Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J Mol Cell Cardiol. 1985 ; 17 (4). 317-338.
76. Todd GL, Baroldi G., Pieper GM, Clayton FC, Eliot RS Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECG, hemodynamic and biochemical changes. J Mol Cell Cardiol. 1985 ; 17 (7). 647-656.
77. Wilkenfeld C., Cohen M., Lansman SL, et al. Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma. J Heart Lung Transplant. 1992 ; 11 (2 pt 1). 363-366.
78. Drislane FW, Samuels MA, Kozakewich H., Schoen FJ, Strunk RC Myocardial contraction band lesions in patients with fatal asthma: possible neurocardiologic mechanisms. Am Rev Respir Dis. 1987 ; 135 (2). 498-501.
79. Lee VH, Oh JK, Mulvagh SL, Wijdicks EF Mechanisms in neurogenic stress cardiomyopathy after aneurismal subarachnoid hemorrhage. Neurocrit Care. 2006 ; 5 (3). 243-249.
80. Kono T., Morita H., Kuroiwa T., Onaka H., Takatsuka H., Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994 ; 24 (3). 636-640.
81. Wang TD, Wu CC, Lee YT Myocardial stunning after cerebral infarction. Int J Cardiol. 1997 ; 58 (3). 308-311.
82. Hudson LD, Milberg JA, Anardi D., et al. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995 ; 151 (2 pt 1). 293-301.
83. Iscimen R., Cartin-Ceba R., Yilmaz M., et al. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med. 2008 ; 36 (5). 1518-1522.
84. Blom HJ, Karsdorp V., Birnie R., Davies G. Phaeochromocytoma as a cause of pulmonary oedema. Anaesthesia. 1987 ; 42 (6). 646-650.
85. Simmons RL, Martin AM Jr, Heisterkamp CA 3rd, Ducker TB Respiratory insufficiency in combat casualties. II. Pulmonary edema following head injury. Ann Surg. 1969 ; 170 (1). 39-44.
86. Macmillan CSA, Grant IS, Andrews PJD. Pulmonary and cardiac sequelae of subarachnoid haemorrhage: time for active management ? Intensive Care Med. 2002 ; 28 (8). 1012-1023.
87. Minnear FL, Connell RS Increased permeability of the capillary-alveolar barriers in neurogenic pulmonary edema (NPE). Microvasc Res. 1981 ; 22 (3). 345-366.
88. Minnear FL, Kite C., Hill LA, van der Zee H. Endothelial injury and pulmonary congestion characterize neurogenic pulmonary edema in rabbits. J Appl Physiol. 1987 ; 63 (1). 335-341.
89. Azevedo AD, Cunha-Melo JR, Freire-Maia L. Arterial hypertension and pulmonary edema induced by catecholamines in unanesthetized rats. Pharmacol Res Commun. 1979 ; 11 (2). 157-167. (Pubitemid 9141169)
90. von Känel R., Dimsdale JE Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol. 2000 ; 65 (6). 357-369.
91. Sterrett C., Brownfield J., Korn CS, Hollinger M., Henderson SO Patterns of presentation in heroin overdose resulting in pulmonary edema. Am J Emerg Med. 2003 ; 21 (1). 32-34.
92. Samet A., Bayoumeu F., Longrois D., Laxenaire MC Acute pulmonary edema associated with the use of beta2-mimetic tocolytic agents. Ann Fr Anesth Reanim. 2000 ; 19 (1). 35-38.
93. Lamont RF. The pathophysiologyof pulmonary edema with the use of beta-agonists. BJOG. 2000 ; 107 (4). 439-444.
94. Senzaki H., Fetics B., Chen CH, Kass DA Comparison of ventricular pressure relaxation assessments in human heart failure: quantitative influence on load and drug sensitivity analysis. J Am Coll Cardiol. 1999 ; 34 (5). 1529-1536.
95. Tatara T., Morisaki H., Shimada M., Ochiai R., Takeda J., Fukushima K. Pulmonary edema after long-term beta-adrenergic therapy and caesarean section. Anesth Analg. 1995 ; 81 (2). 417-418.
96. Berthiaume Y., Staub NC, Matthay MA Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest. 1987 ; 79 (2). 335-343.
97. Westphal M., Daudel F., Bone HG, et al. New approach to an ovine model of hypodynamic endotoxaemia. Eur J Anaesthesiol. 2004 ; 21 (8). 625-631.
98. Wanecek M., Oldner A., Rudehill A., Sollevi A., Alving K., Weitzberg E. Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan. Shock. 1997 ; 7 (5). 364-370.
99. Schreuder WO, Schneider AJ, Groeneveld AB, Thijs LG Effect of dopamine vs. norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance. Chest. 1989 ; 95 (6). 1282-1288.
100. Vincent JL What is right ventricular (dys)function? Crit Care Med. 1994 ; 22 (12). 2024-2026.
101. Redl G., Germann P., Plattner H., Hammerle A. Right ventricular function in early septic shock states. Intensive Care Med. 1993 ; 19 (1). 3-7.
102. Vieillard-Baron A., Schmitt JM, Augarde R., et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med. 2001 ; 29 (8). 1551-1555.
103. Kaul TK, Fields BL Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. Cardiovasc Surg. 2000 ; 8 (1). 1-9.
104. Power I., Kam P. The pulmonary circulation. In: Power I, Kam P, eds. Principles of Physiology for the Anaesthetist. London, England: Edward Arnold; 2001: 88-90.
105. Guyton AC, Hall JE Vascular distensibility, and functions of the arterial and venous systems. In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology. Philadelphia, PA: W.B. Saunders; 2000: 152-161.
106. Smit HJ, Vonk-Noordegraaf A., Boonstra A., de Vries PM, Postmus PE Assessment of the pulmonary volume pulse in idiopathic pulmonary arterial hypertension by means of electrical impedance tomography. Respiration. 2006 ; 73 (5). 597-602.
107. Libre EP, Cowan DH, Watkins SP Jr, Shulman NR Relationships between spleen, platelets and factor 8 levels. Blood. 1968 ; 31 (3). 358-368.
108. Ingram GI, Jones RV, Hershgold EJ, Denson KW, Perkins JR Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoreceptor stimulation. Br J Haematol. 1977 ; 35 (1). 81-100.
109. Mach F., Schönbeck U., Sukhova GK, Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998 ; 394 (6689). 200-203.
110. De Backer D., Creteur J., Preiser JC, Dubois MJ, Vincent JL Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002 ; 166 (1). 98-104.
111. Mertes PM, el- Abbassi K., Jaboin Y., et al. Consequences of coronary occlusion on changes in regional interstitial myocardial neuropeptide Y and norepinephrine concentrations. J Mol Cell Cardiol. 1996 ; 28 (9). 1995-2004.
112. Haft JI, Kranz PD, Albert FJ, Kazem F. Intravascular platelet aggregation in the heart induced by norepinephrine. Circulation. 1972 ; 46 (4). 698-708.
113. Shulkin BL, Shapiro B., Sisson JC Pheochromocytoma, polycythemia, and venous thrombosis. Am J Med. 2 987; 83 (4). 773-776.
114. Stevenson S., Ramani V., Nasim A. Extra-adrenal pheochromocytoma: an unusual cause of deep vein thrombosis. J Vasc Surg. 2005 ; 42 (3). 570-572.
115. Sennoun N., Montemont C., Gibot S., Lacolley P., Levy B. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock. Crit Care Med. 2007 ; 35 (7). 1736-1740.
116. Reinelt H., Radermacher P., Kiefer P., et al. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med. 1999 ; 27 (2). 325-331.
117. Meier-Hellmann A., Reinhart K., Bredle DL, Specht M., Spies CD, Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med. 1997 ; 25 (3). 399-404.
118. Reinelt H., Radermacher P., Fischer G., et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology. 1997 ; 86 (4). 818-824.
119. De Backer D., Berre J., Moraine JJ, Melot C., Vanfraechem J., Vincent JL Effects of dobutamine on the relationship between oxygen consumption and delivery in healthy volunteers: comparison with sodium nitroprusside. Clin Sci (Lond). 1996 ; 90 (2). 105-111.
120. De Backer D., Creteur J., Silva E., Vincent JL Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003 ; 31 (6). 1659-1667.
121. Jakob SM, Merasto-Minkkinen M., Tenhunen JJ, Heino A., Alhava E., Takala J. Prevention of systemic hyperlactatemia during splanchnic ischemia. Shock. 2000 ; 14 (2). 123-127.
122. Heino A., Hartikainen J., Merasto ME, Koski EM, Alhava E., Takala J. Systemic and regional effects of experimental gradual splanchnic ischemia. J Crit Care. 1997 ; 12 (2). 92-98.
123. Schoots IG, Koffeman GI, Legemate DA, Levi M., van Gulik TM Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004 ; 91 (1). 17-27.
124. McDougal MD, West GB The inhibition of the peristaltic reflex by sympathomimetic amines. Br J Pharmacol. 1954 ; 9 (2). 131-137.
125. Doherty NS, Hancock AA Role of alpha-2 adrenergic receptors in the control of diarrhea and intestinal motility. J Pharmacol Exp Ther. 1983 ; 225 (2). 269-274.
126. Kazić T. Effect of adrenergic factors on peristalsis and acetycholine release. Eur J Pharmacol. 1971 ; 16 (3). 367-373.
127. Paton WD, Vizi ES The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol. 1969 ; 35 (1). 10-28.
128. Fruhwald S., Scheidl S., Toller W., et al. Low potential of dobutamine and dopexamine to block intestinal peristalsis as compared with other catecholamines. Crit Care Med. 2000 ; 28 (8). 2893-2897.
129. Ritz MA, Fraser R., Tam W., Dent J. Impacts and patterns of disturbed gastrointestinal function in critically ill patients. Am J Gastroenterol. 2000 ; 95 (11). 3044-3052.
130. Nieuwenhuijs VB, Verheern A., van Duijvenbode-Beumer H., et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg. 1998 ; 228 (2). 188-193.
131. Inglis TJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet. 1993 ; 341 (8850). 911-913.
132. Goodney PP, Stukel TA, Lucas FL, Finlayson EV, Birkmeyer JD Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg. 2003 ; 238 (2). 161-167.
133. Luckey A., Livingston E., Taché Y. Mechanisms and treatment of postoperative ileus. Arch Surg. 2003 ; 138 (2). 206-214.
134. Wang P., Tait SM, Chaudry IH Sustained elevation of norepinephrine depresses hepatocellular function. Biochim Biophys Acta. 2000 ; 1535 (1). 36-44.
135. Aninat C., Seguin P., Descheemaeker PN, Morel F., Malledant Y., Guillouzo A. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med. 2008 ; 36 (3). 848-854.
136. Blaak EE, Van Baak MA, Kempen KP, Saris WH Role of alpha- and beta-adrenoreceptors in sympathetically mediated thermogenesis. Am J Physiol. 1993 ; 264 (1 pt 1). E11 - E17.
137. Meyers DS, Skwish S., Dickinson KE, Kienzle B., Arbeeny CM Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys. J Clin Endocrinol Metab. 1997 ; 82 (2). 395-401.
138. Kaufmann AJ Four beta-adrenoreceptor subtypes in the mammalian heart. Trends Pharmacol Sci. 1997 ; 18 (3). 70-76.
139. Kurose T., Seino Y., Nishi S., et al. Mechanism of sympathetic neural regulation of insulin, somatostatin, and glucagons secretion. Am J Physiol. 1990 ; 258 (1 pt 1). 220-227.
140. Asfar P., Hauser B., Radermacher P., Matejovic M. Catecholamines and vasopressin during critical illness. Crit Care Clin. 2005 ; 22 (1). 131-149. (Pubitemid 43037114)
141. Regan CJ, Duckworth R., Fairhurst JA, et al. Metabolic effects of low-dose dopamine infusion in normal volunteers. Clin Sci (Lond). 1990 ; 79 (6). 605-611.
142. Penn AH, Schmid-Schönbein GW The intestine as source of cytotoxic mediators in shock: free fatty acids and degradation of lipid-binding proteins. Am J Physiol Heart Circ Physiol. 2008 ; 294 (4). H1779 - H1792.
143. Bursten SL, Federighi DA, Parsons P., et al. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Crit Care Med. 1996 ; 24 (7). 1129-1136.
144. Nasraway SA Jr. Hyperglycemia during critical illness. JPEN J Parenter Enteral Nutr. 2006 ; 30 (3). 254-258.
145. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001 ; 345 (19). 1359-1367.
146. van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 ; 354 (5). 449-461.
147. Ensinger H., Weichel T., Lindner KH, Grünert A., Georgieff M. Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient? Intensive Care Med. 1996 ; 21 (1). 50-56.
148. Martikainen TJ, Tenhunen JJ, Giovannini I., Uusaro A., Ruokonen E. Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO(2) content gradients and lactate-to-pyruvate ratios. Am J Physiol Gastrointest Liver Physiol. 2005 ; 288 (3). G586 - G592.
149. Levy B., Bollaert PE, Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism and gastric tonometric variables in septic shock: a prospective randomized study. Intensive Care Med. 1997 ; 23 (3). 282-287.
150. Day NP, Phu NH, Bethell DP, et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic hemodynamics in severe infection. Lancet. 1996 ; 348 (9022). 219-223.
151. Totaro RJ, Raper RF Epinephrine-induced lactic acidosis following cardiopulmonary bypass. Crit Care Med. 1997 ; 25 (10). 1693-1699.
152. Levy B., Gibot S., Franck P., Cravoisy A., Bollaert PE Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet. 2005 ; 365 (9462). 871-875.
153. Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg. 2003 ; 185 (5). 485-491.
154. Bakker J., Coffernils M., Leon M., Gris P., Vincent JL Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest. 1991 ; 99 (4). 956-962.
155. Minneci PC, Deans KJ, Blanks SM, et al. Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock. Am J Physiol Heart Circ Physiol. 2004 ; 287 (6). H2545 - H2554.
156. Ensinger H., Geisser W., Brinkmann A., et al. Metabolic effects of norepinephrine and dobutamine in healthy volunteers. Shock. 2002 ; 18 (6). 495-500.
157. Ensinger H., Rantala A., Vogt J., Georgieff M., Takala J. Effect of dobutamine on splanchnic carbohydrate metabolism and amino acid balance after cardiac surgery. Anesthesiology. 1999 ; 91 (6). 1587-1595.
158. Scheeren TW, Arndt JO Different response of oxygen consumption and cardiac output to various endogenous and synthetic catecholamines in awake dogs. Crit Care Med. 2000 ; 28 (12). 3861-3868.
159. Scheeren TW Relation between oxygen consumption and cardiac output during inhalation anesthesia under the influence of catecholamines. A study in dogs. Anasthesiol Intensivmed Notfallmed Schmerzther. 2000 ; 35 (4). 214-219.
160. Kaltofen A., Lindner KH, Ensinger H., Ahnefeld FW The modification of the potassium concentration in blood by catecholamines. A literature review. Anasth Intensivther Notfallmed. 1990 ; 25 (6). 405-410.
161. Moratinos J., Reverte M. Effects of catecholamines on plasma potassium: the role of alpha- and beta-adrenoreceptors. Fundam Clin Pharmacol. 1993 ; 7 (3-4). 143-153.
162. Beal AL, Scheltema KE, Beilman GJ, Deuser WE Hypokalemia following trauma. Shock. 2002 ; 18 (2). 107-110.
163. Struthers AD, Reid JL Adrenaline causes hypokalaemia in man by beta2 adrenoreceptor stimulation. Clin Endocrinol (Oxf). 1984 ; 20 (4). 409-414.
164. Brown MJ, Brown DC, Murphy MB Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983 ; 309 (23). 1414-1419.
165. Reid JL, Whyte KF, Struthers AD Epinephrine-induced hypokalemia: the role of beta adrenoreceptors. Am J Cardiol. 1986 ; 57 (12). 23-27.
166. Whyte KF, Addis GJ, Whitesmith R., Reid JL Adrenergic control of plasma magnesium in man. Clin Sci (Lond). 1987 ; 72 (1). 135-138.
167. Kleinman G., Nuwayhid B., Rudelstrofer R., et al. Circulatory and renal effects of beta-adrenergic receptor stimulation in pregnant sheep. Am J Obstet Gynecol. 1983 ; 149 (8). 865-874.
168. Tarditi DJ, Hollenberg SM Cardiac arrhythmias in the intensive care unit. Semin Respir Crit Care Med. 2006 ; 27 (3). 221-229.
169. Wahr JA, Parks R., Boisvert D., et al. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Perioperative Ischemia Research Group. JAMA. 1999 ; 281 (23). 2203-2210.
170. Weisberg LS, Szerlip HM, Cox M. Disorders of potassium homeostasis in critically ill patients. Crit Care Clin. 1987 ; 3 (4). 835-854.
171. Landmann R. Beta-adrenergic receptors in human leukocyte subpopulations. Eur J Clin Invest. 1992 ; 22 (suppl 1). 30-36.
172. Muthu K., Deng J., Gamelli R., Shankar R., Jones SB Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis. J Neuroimmunol. 2005 ; 158 (1-2). 50-57.
173. Keller P., Keller C., Robinson LE, Pederson BK Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans. J Appl Physiol. 2004 ; 97 (4). 1309-1312.
174. Stecker W., Gebhard F., Rager J., Bruckner UB, Steinbach G., Kinzl L. Early biochemical characterization of soft-tissue trauma and fracture trauma. J Trauma. 1999 ; 47 (2). 358-364.
175. Fu L., Isobe K., Zeng Q., Suzukawa K., Takekoshi K., Kawakami Y. Beta-adrenoreceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor alpha expression in adipocytes. Eur J Pharmacol. 2007 ; 569 (1-2). 155-162.
176. Schedlowski M., Hosch W., Oberbeck R., et al. Catecholamines modulate human NK cell circulation and function via spleen-independent beta2-adrenergic mechanisms. J Immunol. 1996 ; 156 (1). 93-99.
177. Weiss M., Schneider EM, Tarnow J., et al. Is inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoreceptors ? J Pharmacol Exp Ther. 1996 ; 278 (3). 1105-1113.
178. Horn NA, Anastase DM, Hecker KE, et al. Epinephrine enhances platelet-neutrophil adhesion in whole blood in vitro. Anesth Analg. 2005 ; 100 (2). 520-526.
179. Oberbeck R. Therapeutic implications of immune-endocrine interactions in the critically ill patients. Curr Drug Targets Immune Endocr Metabol Disord. 2004 ; 4 (2). 129-139.
180. Bergmann M., Sautner T. Immunomodulatory effects of vasoactive
181. Friese RS, Barber R., McBride D., Bender J., Gentilello LM Could beta blockade improve outcome after injury by modulating inflammatory profiles ? J Trauma. 2008 ; 64 (4). 1061-1068.
182. Arbabi S., Campion EM, Hemmila MR, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007 ; 62 (1). 56-62.
183. Cotton B., Snodgrass KB, Fleming SB, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007 ; 62 (1). 26-35.
184. Inaba K., Teixeira PG, David JS, et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008 ; 206 (3). 432-438.
185. Riordan WP Jr, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007 ; 63 (3). 503-510 ; discussion 510-511.
186. Arbabi S., Ahrns KS, Wahl WL, et al. Beta-blocker use is associated with improved outcomes in adult burn patients. J Trauma. 2004 ; 56 (2). 265-269 ; discussion 269-271.
187. Evans DG, Miles AA, Niven JS The enhancement of bacterial infections by adrenaline. Br J Exp Pathol. 1948 ; 29 (1). 20-39.
188. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock. 2002 ; 18 (5). 465-470.
189. Lyte M., Freestone PPE, Neal CP, et al. Stimulation of staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet. 2003 ; 361 (9352). 130-135.
190. Freestone PP, Lyte M., Neal CP, Maggs AF, Haigh RD, Williams PH The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferring or lactoferrin. J Bacteriol. 2000 ; 182 (21). 6091-6098.
191. Neal CP, Freestone PP, Maggs AF, Haigh RD, Williams PH, Lyte M. Catecholamine inotropes are growth factors for staphylococcus epidermidis and other coagulase-negative staphylococci. FEMS Microbiol Lett. 2001 ; 194 (2). 163-169.
192. Guyton AC, Hall JE The posterior pituitary gland and its relation to the hypothalamus. In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology. Philadelphia, PA: W.B. Saunders; 2000: 854-857.
193. Sakr Y., Reinhart K., Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med. 2006 ; 34 (3). 589-597.
194. Devins SS, Miller A., Herndon BL, O'Toole L., Reisz G. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med. 1992 ; 20 (12). 1644-1649.
195. Van den Berghe G., de Zegher F., Lauwers P., Veldhuis JD Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrinol Metab. 1994 ; 79 (4). 1141-1146.
196. Van den Berghe G., de Zegher F., Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf). 1994 ; 41 (6). 731-737.
197. Schilling T., Gründling M., Strang CM, Möritz KU, Siegmund W., Hachenberg T. Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. Intensive Care Med. 2004 ; 30 (6). 1127-1133.
198. Brown JE, Adamson JW Modulation of in vitro erythropoiesis: the influence of beta-adrenergic agonists on erythroid colony formation. J Clin Invest. 1977 ; 60 (1). 70-77.
199. Fonseca RB, Mohr AM, Wang L. Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma. Surg Infect (Larchmt). 2004 ; 5 (4). 385-393.
200. Fonseca RB, Mohr AM, Wang L., Sifri ZC, Rameshwar P., Livingston DH The impact of a hyper-catecholamine state on erythropoiesis following severe injury and the role of IL-6. J Trauma. 2005 ; 59 (4). 884-890.
201. Fields RC, Meyers BF The effects of perioperative blood transfusion on morbidity and mortality after esophagectomy. Thorac Surg Clin. 2006 ; 16 (1). 75-86.
202. Burniston JG, Ellison GM, Clark WA, Goldspink DF, Tan LB Relative toxicity of cardiotonic agents: some induce more cardiac and skeletal myocoyte apoptosis and necrosis in vivo than others. Cardiovasc Toxicol. 2005 ; 5 (4). 355-364.
203. Anker SD, Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997 ; 349 (9058). 1050-1053.
204. Ng AL, Goldspink DF, Burniston JG, Clark WA, Colyer J., Tan LB Characterisation of isoprenaline myotoxicity on slow-twitch skeletal versus cardiac muscle. Int J Cardiol. 2002 ; 86 (2-3). 299-309.
205. Gruther W., Benesch T., Zorn C., et al. Muscle wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle layer. J Rehabil Med. 2008 ; 40 (3). 185-189.
206. Chernow B., Lake CR, Zaritsky A., et al. Sympathetic nervous system "switch off" with severe hypothermia. Crit Care Med. 1983 ; 11 (9). 677-680.
207. Johnson DG, Hayward JS, Jacobs TP, Collis ML, Eckerson JD, Williams RH Plasma norepinephrine response of man in cold water. J Appl Physiol Respirat Environ Exercise Physiol. 1977 ; 43 (2). 216-220.
208. Zwischenberger JB, Kirsh MM, Dechert RE, Arnold DK, Bartlett RH Suppression of shivering decreases oxygen consumption and improves hemodynamic stability during postoperative rewarming. Ann Thorac Surg. 1987 ; 43 (4). 428-431.
209. Guyton AC, Hall JE Body temperature, temperature regulation, and fever. In: Guyton AC, Hall JE, eds. Textbook of Medical Physiology. Philadelphia, PA: W.B. Saunders; 2000: 822-833.
210. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized controlled trial. JAMA. 1997 ; 277 (14). 1127-1134.
211. Peres Bota D., Lopes Rerreira F., Mélot C., Vincent JL Body temperature alterations in the critically ill. Intensive Care Med. 2004 ; 30 (5). 811-816.
212. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. 1997 ; 336 (13). 912-918.
213. Barie PS, Hydo LJ, Eachempati SR Causes and consequences of fever complicating critical surgical illness. Surg Infect (Larchmt). 2004 ; 5 (2). 145-159.
214. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ Sedation in the intensive care unit. A systematic review. JAMA. 2000 ; 283 (11). 1451-1459.
215. Hynes-Gay P., Leo M., Molino-Carmona S., et al. Optimizing sedation and analgesia in mechanically ventilated patients - an evidence-based approach. Dynamics. 2003 ; 14 (4). 10-13.
216. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008 ; 371 (9607). 126-134.
217. Plunkett JJ, Reeves JD, Ngo L., et al. Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization: modulation by continuous sedation. Anesthesiology. 1997 ; 86 (4). 785-796.
218. Jacobi J., Fraser GL, Coursin DB, et al. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacist (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in critically ill patients. Crit Care Med. 2002 ; 30 (1). 119-141.
219. Møller IW, Dinesen K., Søndergårfd S., Knigge U., Kehlet H. Effect of patient-controlled analgesia on plasma catecholamine, cortisol and glucose concentrations after cholecystectomy. Br J Anaesth. 1988 ; 61 (2). 160-164.
220. Molina PE Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness. J Int Med. 2006 ; 259 (2). 138-154.
221. Schoffelmeer AN, Rice KC, Jacobson AE, et al. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur J Pharmacol. 1988 ; 154 (2). 169-178.
222. Mistraletti G., Donatelli F., Carli F. Metabolic and endocrine effects of sedative agents. Curr Opin Crit Care. 2005 ; 11 (4). 312-317.
223. Thureson-Klein A. Exocytosis from large and small dense cored vesicles in noradrenergic nerve terminals. Neuroscience. 1983 ; 10 (2). 245-259.
224. Kong KL, Wilatts SM, Prys-Roberts C., Harvey JT, Gorman S. Plasma catecholamine concentration during sedation in ventilated patients requiring intensive therapy. Intensive Care Med. 1990 ; 16 (3). 171-174.
225. Kamijo Y., Masuda T., Nishikawa T., Tsuruta H., Ohwada T. Cardiovascular response and stress reaction to flumazenil injection in patients under infusion with midazolam. Crit Care Med. 2000 ; 28 (2). 318-323.
226. Ronan KP, Gallagher TJ, George B., Hamby B. Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med. 1995 ; 23 (2). 286-293.
227. Crassous PA, Denis C., Paris H., Sénard JM Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem. 2007 ; 7 (2). 187-194.
228. Pouttu J., Tuominem M., Scheinin M., Rosenberg PH Effects of oral clonidine premedication on concentrations of cortisol and monoamine neurotransmitters and their metabolites in cerebrospinal fluid and plasma. Acta Anaesthesiol Scand. 1989 ; 33 (2). 137-141.
229. Schneemilch CE, Bachmann H., Ulrich A., Elwert R., Halloul Z., Hackenberg T. Clonidine decreases stress response in patients undergoing carotid endarterectomy under regional anesthesia: a prospective, randomized, double-blinded, placebo-controlled study. Anesth Analg. 2006 ; 103 (2). 297-302.
230. Dorman T., Clarkson K., Rosenfeld BA, Shanholtz C., Lipsett PA, Breslow MJ Effects of clonidine on prolonged postoperative sympathetic response. Crit Care Med. 1997 ; 25 (7). 1147-1152.
231. Wijeysundera DN, Naik JS, Beattie WS Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta analysis. Am J Med. 2003 ; 114 (9). 742-752.
232. Apzitsch H., Olthoff D., Thieme V., Vetter B., Wiegel M. The effects of perioperative continuous administration of mivazerol on early postoperative hemodynamics and plasma catecholamines after major surgery. Anasthesiol Intensivmed Notfallmed Schmerzther. 2000 ; 35 (8). 515-522.
233. Venn M., Newman J., Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med. 2003 ; 29 (2). 201-207.
234. Shehabi Y., Ruettimann U., Adamson H., Innes R., Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med. 2004 ; 30 (12). 2188-2196.
235. Talke P., Chen R., Thomas B., et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000 ; 90 (4). 834-839.
236. Willigers HM, Prinzen FW, Roekaerts PM, de Lange S., Durieux ME Dexmedetomidine decreases perioperative myocardial lactate release in dogs. Anesth Analg. 2003 ; 96 (3). 657-664.
237. Knotzer H., Mayr A., Ulmer H., et al. Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med. 2000 ; 26 (7). 908-914.
238. Mayr A., Ritsch N., Knotzer H., et al. Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients. Crit Care Med. 2003 ; 31 (2). 401-405.
239. Mayr AJ, Dünser MW, Ritsch N., et al. High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study. Wien Klin Wochenschr. 2004 ; 116 (9-10). 310-317.
240. Knotzer H., Dünser MW, Mayr AJ, Hasibeder WR Postbypass arrhythmias: pathophysiology, prevention, and therapy. Curr Opin Crit Care. 2004 ; 10 (5). 330-335.
241. Wyse DG, Waldo Al, DiMarco JP, et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002 ; 347 (23). 1825-1833.
242. Van Gelder IC, Hagens VE, Bosker A., et al. A comparison of rate control and rhythm control control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002 ; 347 (23). 1834-1840.
243. Trappe HJ, Brandts B., Weismueller P. Arrhythmias in the intensive care patient. Curr Opin Crit Care. 2003 ; 9 (5). 345-355.
244. Azimi G., Vincent JL Ultimate survival from septic shock. Resuscitation. 1986 ; 14 (4). 245-253.
245. Parker MM, Shelhamer JH, Natanson C., Alling DW, Parrillo JE Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med. 1987 ; 15 (10). 923-929.
246. Mangano DT, Layug EL, Wallace A., Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996 ; 335 (23). 1713-1720.
247. Fleisher LA, Eagle KA Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med. 2001 ; 345 (23). 1677-1682.
248. Suttner SW, Piper SN, Boldt J. The heart in the elderly critically ill patient. Curr Opin Crit Care. 2002 ; 8 (5). 389-394.
249. Wallace A., Layug B., Tateo I., et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology. 1998 ; 88 (1). 7-17. (Pubitemid 128721126)
250. Eagle KA, Berger PB, Calkins H., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). ACC/AHA guidelines update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002 ; 105 (10). 1257-1267.
251. Meldrum DR Beta-blockade during sepsis: inspired or insane ? Crit Care Med. 2005 ; 33 (10). 2433-2434.
252. Suzuki T., Morisaki H., Serita R., et al. Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med. 2005 ; 33 (10). 2294-2301.
253. Gore DC, Wolfe RR Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis. Surgery. 2006 ; 139 (5). 686-694.
254. Schmittinger CA, Dünser MW, Haller M., et al. Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care. 2008 ; 12 (4). R99.
255. Dünser MW, Hasibeder WR Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart!. Crit Care. 2006 ; 10 (6). 172.
256. Varpula M., Tallgren M., Saukkonen K., Voipio-Pulkki LM, Pettilä V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005 ; 31 (8). 1066-1071.
257. Dünser MW, Daudel F., Luckner G., et al. Arterial blood pressure during early sepsis. Intensive Care Med. 2007 ; 33 (suppl 2). A125.
258. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 ; 345 (19). 1368-1377.
259. Bracht H., Hänggi M., Jeker B., et al. Incidence of low central venous oxygen saturation during unplanned admissions in a multidisciplinary intensive care unit: an observational study. Crit Care. 2007 ; 11 (1). R2.
260. Hayes MA, Timmins AC, Yau EH, Palazzo M., Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994 ; 330 (24). 1717-1722. (Pubitemid 24171030)
261. Rivers EP, Ander DS, Powell D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001 ; 7 (3). 204-211.
262. Reinhart K., Sakka SG, Meier-Hellmann A. Haemodynamic management of a patient with septic shock. Eur J Anaesthesiol. 2000 ; 17 (1). 6-17.
263. Parker MM Goals of fluid resuscitation: a real challenge. Crit Care Med. 2007 ; 35 (1). 295-296.
264. Silva E., De Backer D., Creteur J., Vincent JL Effects of fluid challenge on gastric mucosal PCO2 in septic patients. Intensive Care Med. 2004 ; 30 (3). 423-429.
265. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology. 2006 ; 104 (3). 556-569.
266. Haikala H., Nissinen E., Etemadzadeh E., Levijoki J., Lindén IB. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol. 1995 ; 25 (5). 794-801.
267. McGough MF, Pagel PS, Lowe D., Hettrick DA, Kersten JR, Warltier DC Effects of levosimendan on left ventricular function: correlation with plasma concentrations in conscious dogs. J Cardiothorac Vasc Anesth. 1997 ; 11 (1). 49-53. (Pubitemid 27114208)
268. Sonntag S., Sundberg S., Lehtonen LA, Kleber FX The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol. 2004 ; 43 (12). 2177-2182.
269. Lilleberg J., Nieminen MS, Akkila J., et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998 ; 19 (4). 660-668.
270. Du Toit EF, Muller CA, McCarthy J., Opie LH Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleoside levels during ischemia/ reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther. 1999 ; 290 (2). 505-514.
271. Rump AF, Acar D., Rösen R., Klaus W. Functional and antiischaemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts. Pharmacol Toxicol. 1994 ; 74 (4-5). 244-248. (Pubitemid 24154962)
272. Kersten JR, Montgomery MW, Pagel PS, Warltier DC Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg. 2000 ; 90 (1). 5-11.
273. Moiseyev VS, Poder P., Andrejevs N., et al. RUSSLAN Study Investigators. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 2002 ; 23 (18). 1422-1432.
274. Alhashemi JA Treatment of cardiogenic shock with levosimendan in combination with β-adrenergic antagonists. Br J Anaesth. 2005 ; 95 (5). 648-650.
275. Siraux V., De Backer D., Yalavatti G., et al. Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests. Crit Care Med. 2005 ; 33 (11). 2479-2486.
276. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999 ; 27 (4). 723-732.
277. Bollaert PE, Charpentier C., Levy B., Debouverie M., Audibert G., Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998 ; 26 (4). 645-650.
278. Kilger E., Weis F., Briegel J., et al. Stress doses of hydrocortisone reduce systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med. 2003 ; 31 (4). 1068-1074.
279. Annane D., Bellissant E., Bollaert PE, Briegel J., Keh D., Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004 ; 329 (7464). 480-488.
280. Annane D., Sébille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002 ; 288 (7). 862-871.
281. Sprung CL, Annane D., Keh D., et al. CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008 ; 358 (2). 111-124.
282. Dünser MW, Lindner KH, Wenzel V. A century of arginine vasopressin research leading to new therapeutic strategies. Anesthesiology. 2006 ; 105 (3). 444-445.
283. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004 ; 30 (7). 1276-1291.
284. Dünser MW, Mayr AJ, Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003 ; 107 (18). 2313-2319.
285. Dünser MW, Mayr AJ, Ulmer H., et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg. 2001 ; 93 (1). 7-13.
286. Evora PR, Pearson PJ, Schaff HV Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 1993 ; 103 (4). 1241-1245.
287. Dünser MW, Fries DR, Schobersberger W., et al. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome ? Anesth Analg. 2004 ; 99 (1). 201-206.
288. Luckner G., Dünser MW, Jochberger S., et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med. 2005 ; 33 (11). 2659-2666.
289. Russell JA, Walley KR, Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 ; 358 (9). 877-887.